文献速递心外重症与机械循环支持先天性心脏病外科

低体重儿童使用柏林心脏EXCOR心室辅助装置生存率改善

Improvement of survival in low-weight children on the Berlin Heart EXCOR ventricular assist device support†.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

本研究基于柏林心脏EXCOR前瞻性登记(n=1832),回顾性分析2000-2017年不同体重组(<5 kg、5-10 kg、>10 kg)在不同年代(2000-2012 vs 2013-2017)的生存差异。结果显示<5 kg和5-10 kg组生存率显著提高,而>10 kg组保持稳定;在<5 kg组中,先天性心脏病、术前体外生命支持和双心室支持在早期与死亡率独立相关,但在近期不再显著。结论认为EXCOR治疗在<10 kg患者中显著改善,不应仅因体重而放弃心室辅助装置。

要点

  • <5 kg和5-10 kg患儿EXCOR辅助生存率近年显著提高。
  • >10 kg患儿生存率保持稳定,近期5-10 kg组与>10 kg组无显著差异。
  • 不应仅因体重低而放弃EXCOR心室辅助装置治疗。

核心结论

  • 儿童EXCOR心室辅助装置治疗在体重<10 kg患者中显著改善,不应仅根据体重决定是否使用。

研究设计与样本

  • 基于柏林心脏EXCOR前瞻性登记(n=1832)的回顾性研究,比较2000-2017年间不同体重组(A组<5 kg,n=204;B组5-10 kg,n=633;C组>10 kg,n=995)在不同年代(年代1:2000年1月-2012年12月,n=1089;年代2:2013年1月-2017年6月,n=743)的结局。

主要发现

  • A组总体生存率从年代1的51%升至年代2的65%(P<0.001),B组从74%升至78%(P=0.001),C组保持稳定(78% vs 73%)。
  • 在年代2,B组与C组生存率无显著差异。
  • 在<5 kg患儿的多变量分析中,年代1先天性心脏病、术前体外生命支持和双心室支持的死亡风险比分别为2.04(95%CI 1.18-3.53)、2.44(1.36-4.37)和1.93(1.11-3.34),但在年代2不显著。

临床怎么用

  • 对于体重<10 kg的儿童,应考虑使用EXCOR心室辅助装置,不应仅因体重低而放弃。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Publications on the paediatric Berlin Heart EXCOR ventricular assist device have revealed that low body weight <10 kg is a significant risk factor for mortality with children weighing <5 kg being at the highest risk. However, these studies are limited to implantation periods prior to 2011. Since then, progress has been made in the optimization of patient selection and management. This study investigated whether the survival of children weighing <10 kg supported with the EXCOR assist device has improved in recent years and sought to determine the risk factors for mortality. METHODS: The Berlin Heart EXCOR prospective registry (n = 1832) was retrospectively reviewed between 2000 and 2017 to compare the outcomes of different weight cohorts: A (<5 kg; n = 204), B (5-10 kg; n = 633) and C (>10 kg; n = 995) in different eras [era 1: January 2000-December 2012 (n = 1089) and era 2: January 2013-June 2017 (n = 743)]. RESULTS: Overall survival in groups A and B significantly increased from era 1 to era 2 (group A 51% vs 65%, P < 0.001; group B 74% vs 78%, P = 0.001), whereas it remained stable in group C (78% vs 73%). In era 2, the survival of group B was not significantly different from group C. On the multivariable analysis of children weighing <5 kg, congenital heart disease, preoperative extracorporeal life support and biventricular support were independently associated with increased mortality in era 1 [hazard ratio 2.04 (95% confidence interval 1.18-3.53); 2.44 (1.36-4.37) and 1.93 (1.11-3.34), respectively] but not in era 2. CONCLUSIONS: Paediatric EXCOR ventricular assist device therapy has significantly improved for patients weighing <10 kg. Withholding a ventricular assist device is not justified on the basis of the body weight alone.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Miera O, Morales DLS, Thul J, et al. Improvement of survival in low-weight children on the Berlin Heart EXCOR ventricular assist device support†. Eur J Cardiothorac Surg. 2019. PMID: 30590433. doi:10.1093/ejcts/ezy394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。